These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1107435)

  • 1. Pharmacokinetics of ticarcillin in patients with abnormal renal function.
    Parry MF; Neu HC
    J Infect Dis; 1976 Jan; 133(1):46-9. PubMed ID: 1107435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function.
    Jungbluth GL; Cooper DL; Doyle GD; Chudzik GM; Jusko WJ
    Antimicrob Agents Chemother; 1986 Dec; 30(6):896-900. PubMed ID: 3492959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of ticarcillin in patients with normal and impaired renal function (author's transl)].
    Höffler D; Dalhoff A; Koeppe P
    Dtsch Med Wochenschr; 1978 Jun; 103(22):931-5. PubMed ID: 350535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the combination of ticarcillin with clavulanic acid in renal insufficiency.
    Dalet F; Amado E; Cabrera E; Donate T; del Rio G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():57-64. PubMed ID: 3722047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo inactivation of tobramycin by ticarcillin. A case report.
    Chow MS; Quintiliani R; Nightingale CH
    JAMA; 1982 Feb; 247(5):658-9. PubMed ID: 6798229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of clavulanic acid-potentiated ticarcillin in renal failure.
    Watson ID; Boulton-Jones M; Stewart MJ; Henderson I; Payton CD
    Ther Drug Monit; 1987 Jun; 9(2):139-47. PubMed ID: 3617151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1980 Nov; 20(5):325-52. PubMed ID: 7002527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ticarcillin in patients with cystic fibrosis: a controlled prospective study.
    de Groot R; Hack BD; Weber A; Chaffin D; Ramsey B; Smith AL
    Clin Pharmacol Ther; 1990 Jan; 47(1):73-8. PubMed ID: 2295222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of carbenicillin and ticarcillin with gentamicin.
    Davies M; Morgan JR; Anand C
    Antimicrob Agents Chemother; 1975 Apr; 7(4):431-4. PubMed ID: 1147579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentamicin and ticarcillin in subjects with end-stage renal disease. Comparison of two assay methods and evaluation of inactivation rate.
    Russo ME; Atkin-Thor E
    Clin Nephrol; 1981 Apr; 15(4):175-80. PubMed ID: 7237864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics.
    Meyers BR; Hirschman SZ; Strougo L; Srulevitch E
    Antimicrob Agents Chemother; 1980 Apr; 17(4):608-11. PubMed ID: 6446878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ticarcillin on gentamicin and tobramycin pharmacokinetics in a patient with end-stage renal disease.
    Matzke GR; Luckham DR; Collins AJ; Halstenson CE
    Pharmacotherapy; 1984; 4(3):158-60. PubMed ID: 6739313
    [No Abstract]   [Full Text] [Related]  

  • 13. Ticarcillin: pharmacokinetics in man according to different administration schedules.
    Dalhoff A; Höffler D
    J Int Med Res; 1977; 5(5):308-21. PubMed ID: 913858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pharmacological studies of ticarcillin in gram-negative infections.
    Ervin FR; Bullock WE
    Antimicrob Agents Chemother; 1976 Jan; 9(1):94-101. PubMed ID: 769676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic studies on clavulanate potentiated ticarcillin in normal subjects and patients with renal insufficiency.
    Koeppe P; Höffler D; Hulla FW
    Arzneimittelforschung; 1987 Feb; 37(2):203-8. PubMed ID: 3580024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D; Schurig R; Weihermüller K; Förster D
    Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of experimental tobramycin nephrotoxicity by ticarcillin.
    English J; Gilbert DN; Kohlhepp S; Kohnen PW; Mayor G; Houghton DC; Bennett WM
    Antimicrob Agents Chemother; 1985 Jun; 27(6):897-902. PubMed ID: 4026263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin.
    Wang JP; Unadkat JD; al-Habet SM; O'Sullivan TA; Williams-Warren J; Smith AL; Ramsey B
    Clin Pharmacol Ther; 1993 Sep; 54(3):293-302. PubMed ID: 8375124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ticarcillin in the horse after intravenous and intramuscular administration.
    Sweeney CR; Soma LR; Beech J; Reef V; Simmons R
    Am J Vet Res; 1984 May; 45(5):1000-2. PubMed ID: 6732002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticarcillin vs carbenicillin: clinical pharmacokinetics.
    Libke RD; Clarke JT; Ralph ED; Luthy RP; Kirby WM
    Clin Pharmacol Ther; 1975 Apr; 17(4):441-6. PubMed ID: 1122685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.